
Daniel R. Carcanague
Examiner (ID: 5382, Phone: (571)270-3023 , Office: P/1625 )
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1621, 1625 |
| Total Applications | 1087 |
| Issued Applications | 878 |
| Pending Applications | 22 |
| Abandoned Applications | 208 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12233068
[patent_doc_number] => 20180065931
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-08
[patent_title] => 'METHOD FOR PRODUCING 1-(4-HYDROXYPHENYL)-4-(4-TRIFLUOROMETHOXYPHENOXY)PIPERIDINE OR SALT THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/561602
[patent_app_country] => US
[patent_app_date] => 2016-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12055
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15561602
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/561602 | Method for producing 1-(4-hydroxyphenyl)-4-(4-trifluoromethoxyphenoxy)piperidine or salt thereof | Mar 24, 2016 | Issued |
Array
(
[id] => 14213657
[patent_doc_number] => 20190119213
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-25
[patent_title] => OXO-PYRIDINE-DERIVATIVES AS FACTOR XIA INHIBITORS FOR THE TREATMENT OF THROMBOSIS
[patent_app_type] => utility
[patent_app_number] => 15/557831
[patent_app_country] => US
[patent_app_date] => 2016-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19689
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15557831
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/557831 | OXO-PYRIDINE-DERIVATIVES AS FACTOR XIA INHIBITORS FOR THE TREATMENT OF THROMBOSIS | Mar 14, 2016 | Abandoned |
Array
(
[id] => 14665029
[patent_doc_number] => 10370405
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-06
[patent_title] => C-3 novel triterpenone with C-28 amide derivatives as HIV inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/558677
[patent_app_country] => US
[patent_app_date] => 2016-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23244
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15558677
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/558677 | C-3 novel triterpenone with C-28 amide derivatives as HIV inhibitors | Mar 11, 2016 | Issued |
Array
(
[id] => 12584631
[patent_doc_number] => 20180086706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-29
[patent_title] => HYDRATE OF 2-ISOPROPOXY-5-METHYL-4-(PIPERIDIN-4-YL) ANILINE DIHYDROCHLORIDE, PREPARATION METHOD AND USE OF THE SAME
[patent_app_type] => utility
[patent_app_number] => 15/561730
[patent_app_country] => US
[patent_app_date] => 2016-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3464
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15561730
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/561730 | Hydrate of 2-isopropoxy-5-methyl-4-(piperidin-4-yl) aniline dihydrochloride, preparation method and use of the same | Mar 1, 2016 | Issued |
Array
(
[id] => 12185357
[patent_doc_number] => 20180044294
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-15
[patent_title] => 'Process for preparing piperidine-4-carbothioamide hydrochloride'
[patent_app_type] => utility
[patent_app_number] => 15/555861
[patent_app_country] => US
[patent_app_date] => 2016-02-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1544
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15555861
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/555861 | Process for preparing piperidine-4-carbothioamide hydrochloride | Feb 28, 2016 | Issued |
Array
(
[id] => 12813103
[patent_doc_number] => 20180162871
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-14
[patent_title] => FLUORESCENT PROBE FOR DETECTING CALPAIN ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 15/553970
[patent_app_country] => US
[patent_app_date] => 2016-02-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5800
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15553970
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/553970 | Fluorescent probe for detecting calpain activity | Feb 28, 2016 | Issued |
Array
(
[id] => 11009657
[patent_doc_number] => 20160206609
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-21
[patent_title] => 'NEUROPROTECTIVE POLYPHENOL ANALOGS'
[patent_app_type] => utility
[patent_app_number] => 15/054906
[patent_app_country] => US
[patent_app_date] => 2016-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 41627
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15054906
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/054906 | Neuroprotective polyphenol analogs | Feb 25, 2016 | Issued |
Array
(
[id] => 12172027
[patent_doc_number] => 09890155
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-02-13
[patent_title] => 'Aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection'
[patent_app_type] => utility
[patent_app_number] => 15/041950
[patent_app_country] => US
[patent_app_date] => 2016-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13592
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15041950
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/041950 | Aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection | Feb 10, 2016 | Issued |
Array
(
[id] => 11032847
[patent_doc_number] => 20160229803
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-11
[patent_title] => 'ELECTROCHROMIC COMPOUNDS WITH IMPROVED COLOR STABILITY IN THEIR RADICAL STATES'
[patent_app_type] => utility
[patent_app_number] => 15/040946
[patent_app_country] => US
[patent_app_date] => 2016-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13377
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15040946
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/040946 | Electrochromic compounds with improved color stability in their radical states | Feb 9, 2016 | Issued |
Array
(
[id] => 14268287
[patent_doc_number] => 10283716
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-07
[patent_title] => Compound for organic electric element, organic electric element using the same, and electronic device comprising same
[patent_app_type] => utility
[patent_app_number] => 15/549467
[patent_app_country] => US
[patent_app_date] => 2016-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9448
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15549467
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/549467 | Compound for organic electric element, organic electric element using the same, and electronic device comprising same | Feb 3, 2016 | Issued |
Array
(
[id] => 12151481
[patent_doc_number] => 20180022745
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-25
[patent_title] => 'ISOQUINILINE AND NAPTHALENE-SUBSTITUTED COMPOUNDS AS MGLUR4 ALLOSTERIC POTENTIATORS, COMPOSITIONS, AND METHODS OF TREATING NEUROLOGICAL DYSFUNCTION'
[patent_app_type] => utility
[patent_app_number] => 15/547775
[patent_app_country] => US
[patent_app_date] => 2016-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 35834
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15547775
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/547775 | Isoquiniline and napthalene-substituted compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction | Jan 31, 2016 | Issued |
Array
(
[id] => 11722354
[patent_doc_number] => 09695200
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-07-04
[patent_title] => 'Heterocyclic ITK inhibitors for treating inflammation and cancer'
[patent_app_type] => utility
[patent_app_number] => 15/005627
[patent_app_country] => US
[patent_app_date] => 2016-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52774
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15005627
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/005627 | Heterocyclic ITK inhibitors for treating inflammation and cancer | Jan 24, 2016 | Issued |
Array
(
[id] => 12466059
[patent_doc_number] => 09987259
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-05
[patent_title] => Pharmaceutical composition comprising pyridone derivatives
[patent_app_type] => utility
[patent_app_number] => 14/997754
[patent_app_country] => US
[patent_app_date] => 2016-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6927
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14997754
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/997754 | Pharmaceutical composition comprising pyridone derivatives | Jan 17, 2016 | Issued |
Array
(
[id] => 11828712
[patent_doc_number] => 09725446
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-08
[patent_title] => '7-azaindole derivatives'
[patent_app_type] => utility
[patent_app_number] => 14/987946
[patent_app_country] => US
[patent_app_date] => 2016-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17075
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14987946
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/987946 | 7-azaindole derivatives | Jan 4, 2016 | Issued |
Array
(
[id] => 12769852
[patent_doc_number] => 20180148452
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-31
[patent_title] => TOLL-LIKE RECEPTOR-7 AGONIST
[patent_app_type] => utility
[patent_app_number] => 15/573990
[patent_app_country] => US
[patent_app_date] => 2015-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14201
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15573990
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/573990 | TOLL-LIKE RECEPTOR-7 AGONIST | Dec 28, 2015 | Abandoned |
Array
(
[id] => 10979928
[patent_doc_number] => 20160176871
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-23
[patent_title] => 'TGF BETA R ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 14/977709
[patent_app_country] => US
[patent_app_date] => 2015-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 93937
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14977709
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/977709 | TGFβR antagonists | Dec 21, 2015 | Issued |
Array
(
[id] => 13699583
[patent_doc_number] => 20170360746
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-21
[patent_title] => POLYMORPH OF GRANATICIN B
[patent_app_type] => utility
[patent_app_number] => 15/538744
[patent_app_country] => US
[patent_app_date] => 2015-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12728
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15538744
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/538744 | Polymorph of granaticin B | Dec 21, 2015 | Issued |
Array
(
[id] => 12118733
[patent_doc_number] => 20180002319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-04
[patent_title] => 'MACROCYCLIC PICOLINAMIDE COMPOUNDS WITH FUNGICIDAL ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 15/540570
[patent_app_country] => US
[patent_app_date] => 2015-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 91332
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15540570
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/540570 | MACROCYCLIC PICOLINAMIDE COMPOUNDS WITH FUNGICIDAL ACTIVITY | Dec 20, 2015 | Abandoned |
Array
(
[id] => 12305733
[patent_doc_number] => 09938276
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-10
[patent_title] => 6,5-bicyclic octahydropyrrolopyridine orexin receptor antagonists
[patent_app_type] => utility
[patent_app_number] => 15/531846
[patent_app_country] => US
[patent_app_date] => 2015-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21072
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15531846
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/531846 | 6,5-bicyclic octahydropyrrolopyridine orexin receptor antagonists | Dec 13, 2015 | Issued |
Array
(
[id] => 11010955
[patent_doc_number] => 20160207909
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-21
[patent_title] => 'Synthesis Method of Anti-Cancer Drug UK-1 and Derivatives Thereof'
[patent_app_type] => utility
[patent_app_number] => 14/964651
[patent_app_country] => US
[patent_app_date] => 2015-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4002
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14964651
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/964651 | Synthesis Method of Anti-Cancer Drug UK-1 and Derivatives Thereof | Dec 9, 2015 | Abandoned |